Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Allogenic Bone Marrow Transplantation”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00896493
What this trial is testing

Ph II of Non-myeloablative Allogeneic Transplantation Using TLI & ATG In Patients w/ Cutaneous T Cell Lymphoma

Who this might be right for
MycosesSezary SyndromeLymphoma, T-Cell, Cutaneous+3 more
Stanford University 38
Very early researchEnded earlyNCT03272633
What this trial is testing

Irradiated Donor Cells Following Stem Cell Transplant in Controlling Cancer in Patients With Hematologic Malignancies

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid Leukemia in RemissionHematopoietic Cell Transplantation Recipient+16 more
Rutgers, The State University of New Jersey 2
Not applicableEnded earlyNCT01326728
What this trial is testing

Relapsed Malignant Blood Cancer After Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Chronic Myelogenous LeukemiaAcute Myelogenous LeukemiaAcute Lymphoblastic Leukemia+2 more
National Cancer Institute (NCI) 56
Testing effectiveness (Phase 2)Study completedNCT01338987
What this trial is testing

Pilot Study of Leuprolide to Improve Immune Function After Allogeneic Bone Marrow Transplantation

Who this might be right for
Myelodysplastic SyndromeAcute Lymphocytic LeukemiaAcute Myelogenous Leukemia+2 more
National Cancer Institute (NCI) 76
Testing effectiveness (Phase 2)Ended earlyNCT01570348
What this trial is testing

Crohn's Allogeneic Transplant Study

Who this might be right for
Crohn Disease
Fred Hutchinson Cancer Center 2
Testing effectiveness (Phase 2)Study completedNCT02133924
What this trial is testing

Multicenter Study Of Natalizumab Plus Standard Steroid Treatment For High Risk Acute Graft-Versus-Host Disease

Who this might be right for
Acute Graft Versus Host Disease
John Levine 76
Not applicableStudy completedNCT00619879
What this trial is testing

Myeloablative Hematopoietic Progenitor Cell Transplantation (HPCT) for Pediatric Malignancies

Who this might be right for
Leukemia, Myelogenous, ChronicLeukemia, Lymphoblastic, AcuteLeukemia, Myelogenous, Acute+2 more
Ann & Robert H Lurie Children's Hospital of Chicago 81
Large-scale testing (Phase 3)Study completedNCT00354120
What this trial is testing

Thymoglobuline Versus Alemtuzumab in Patients Undergoing Allogeneic Transplant

Who this might be right for
Acute Myeloblastic LeukemiaLymphoblastic LeukemiaMyelodysplasia+3 more
Gruppo Italiano Trapianto di Midollo Osseo 121
Testing effectiveness (Phase 2)Temporarily pausedNCT01709396
What this trial is testing

ED-TBI Followed By Allogeneic Stem Cell Transplantation For The Treatment Of Refractory AML And Advanced MDS

Who this might be right for
Acute LeukemiaMyelodysplastic Syndrome
Ottawa Hospital Research Institute 20
Testing effectiveness (Phase 2)Study completedNCT02684162
What this trial is testing

Guadecitabine and Donor Lymphocyte Infusion in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Relapsing After Allogeneic Stem Cell Transplant

Who this might be right for
Acute Myeloid LeukemiaChronic Myelomonocytic LeukemiaMyelodysplastic Syndrome+2 more
M.D. Anderson Cancer Center 55
Testing effectiveness (Phase 2)Study completedNCT00533923
What this trial is testing

Nonmyeloablative Allogeneic Stem Cell Transplantation From HLA-Matched Unrelated Donor for the Treatment of Hematologic Disorders

Who this might be right for
AMLALLCLL+6 more
Beth Israel Deaconess Medical Center 25
Early research (Phase 1)Study completedNCT00003962
What this trial is testing

Interleukin-2 Following Bone Marrow Transplantation in Treating Patients With Hematologic Cancer

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Testing effectiveness (Phase 2)Study completedNCT01810120
What this trial is testing

Trial to Assess the Efficacy of a TCR Alfa Beta Depleted Graft in Pediatric Affected by ALL or AML and Receiving an HSCT

Who this might be right for
Acute Lymphoblastic LeukemiaLeukemia Acute Myeloid - AMLNon-Hodgkin Lymphoma+1 more
Mariella Enoc 30
Testing effectiveness (Phase 2)WithdrawnNCT00396968
What this trial is testing

AMD3100 With Busulfan, Fludarabine and Thymoglobulin for Allogeneic Stem Cell Transplant for AML and MDS

Who this might be right for
Acute Myelogenous LeukemiaMyelodysplastic Syndromes
Genzyme, a Sanofi Company
Testing effectiveness (Phase 2)Study completedNCT00572897
What this trial is testing

Study of Fludarabine Based Conditioning for Allogeneic Stem Cell Transplantation for Myelofibrosis

Who this might be right for
Myelofibrosis
John Mascarenhas 66
Not applicableStudy completedNCT02604420
What this trial is testing

Identification and Treatment of Thrombotic Microangiopathies in Allogeneic Stem Cell Transplants

Who this might be right for
Thrombotic MicroangiopathyDisorder Related to Bone Marrow Transplantation
Weill Medical College of Cornell University 200
Testing effectiveness (Phase 2)Study completedNCT01560689
What this trial is testing

Inhaled BUDESONIDE/FORMOTEROL in Bronchiolitis Obliterans Following Stem Cell Transplantation

Who this might be right for
Bronchiolitis ObliteransAllogeneic Stem Cell Transplantation
Assistance Publique - Hôpitaux de Paris 32
Early research (Phase 1)Looking for participantsNCT07565220
What this trial is testing

Thiotepa-based Conditioning Regimen With De-escalated Post-graft Cyclophosphamide for Allogeneic Stem Cell Transplantation in Hematologic Malignancies

Who this might be right for
Acute Lymphocytic Leukemia (ALL)Acute Myeloid Leukemia (AML)Acute Leukemia+2 more
Sawa Ito, MD 48
Testing effectiveness (Phase 2)Study completedNCT02989844
What this trial is testing

Relapse Prophylaxis With N-803 for AML and MDS Pts Following Allo HSCT

Who this might be right for
Acute Myelogenous Leukemia (AML)Myelodysplastic Syndrome (MDS)
Masonic Cancer Center, University of Minnesota 20
Post-approval studies (Phase 4)UnknownNCT03150134
What this trial is testing

Early Tapering of Immunosuppressive Agents to Immunomodulation to Improve Survival of AML Patients

Who this might be right for
Acute Myeloid LeukemiaDisorder Related to Bone Marrow Transplantation
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 100
Next Page